# MarketFlow Predictive Usefulness Reassessment Review Rerun Using Refined Evidence Status

## Branch And Scope

- Branch: `feature/predictive-usefulness-reassessment-review-rerun-refined-evidence-v1`.
- Base commit: `fb12de8e744f1bf0a9b8386489fa71d0a0f4e719`.
- Commit: recorded by this document's implementing commit after validation.
- Scope: offline, digest-bound reassessment of the reviewed refined-evidence facts. This task creates no acceptance-readiness review, predictive-usefulness acceptance, profitability acceptance, runtime migration, strategy, paper, broker, scoring, or recommendation authority.

## Review Artifact And Status

- Artifact/status: `PREDICTIVE_USEFULNESS_REASSESSMENT_REVIEW_RERUN_USING_REFINED_EVIDENCE_PACKAGE` / `PREDICTIVE_USEFULNESS_REASSESSMENT_REVIEW_RERUN_USING_REFINED_EVIDENCE_PACKAGE_READY`.
- Schema: `predictive_usefulness_reassessment_review_rerun_using_refined_evidence_v1`.
- Review digest: `7520cd1c2f8d727ad7e94c0313c78e8bbb39bae410feeda539dd242ede28fcc0`.
- Checklist: `76 / 76` passed, `0` failed, and `0` blockers.
- Reassessment rerun created/ready: `True / True`.
- Ready for a separate Predictive Usefulness Acceptance Readiness Review Rerun Using Refined Evidence: `True`.

## Source Refined-Evidence Results Review

- Results-review digest: `539d06be9b20edee5ff883030e4fd1091fdaefb468fa595001178bf7ec0740da`.
- Refined-evidence execution digest: `9cf962933620f066dfb105845428a262743f9f36dbc2850838321f23de10b5fd`.
- Refined-evidence execution approval digest: `5ad7b3b8df3156ab6b35b9490dcd4ae05bda3d1a7786212481b78d549103a8dd`.
- Feature/label refinement results-review/execution digests: `00604008d3c647f45896cd8b6707de519ed6eda4e32566b3c99910441ec6cc79` / `377d6d232dcdf4b94f9f2d66414ff994edca2d3d9d95f4fb97d9dbfaf2359b36`.
- Original additional predictive-evidence results-review/execution digests: `167a0399e99f46e895c9cdf6c70a3e650e20f60cb78641180de04e56f88caee8` / `61a90d0b863da3ddfc3ef8eb744a1ef64c476a975d83faa2be19d0f199776ed3`.
- Research-registry approval digest: `5f0ce29bd06f1a0d5f1ce3dd8e31b8c8e52d616673f119326377538228d3d958`.
- Canonical freeze/records digests: `02af746fa11fa292a84e000ff8ca19a0b4ab36937558f938e4ac04eef6be92fc` / `fbd7c1b17b42e5d4f82a9162b31b45fdfeef46f0e9ee7d29d74c926f0cf19044`.

## Registry-Approved Dataset Metadata

- Dataset/scope/status: `expanded_universe_canonical_dataset_v1` / `CANONICAL_DATASET_GENERATION_RESEARCH_ONLY` / `APPROVED_FOR_RESEARCH_REGISTRY_ONLY`.
- Source profile/timeframe/range: `RTH_FULL_SESSION_1D` / `1d` / `2022-01-01` through `2025-12-31`.
- Registry label/data quality: `RESEARCH_ONLY_NON_ACTIONABLE` / `PASS_WITH_PRESERVED_SOURCE_LIMITATION`.
- Exact universe: `MSFT`, `NVDA`, `AMZN`, `GOOGL`, `META`, `TSLA`, `JPM`, `XOM`, `JNJ`, `WMT`, `CAT`, `LMT`.
- Total records: `11946`; META remains `913`, and every other ticker remains `1003`.

## Refined Evidence Facts

- Existing refined outputs/failures/warnings: `10 / 0 / 1`; the warning preserves META's reduced record count.
- Labels: `7` families, `82698` available values, and `924` unavailable values.
- Features: `9` groups, `11` categories, `19` fields, and `11946` rows.
- Protocol: `6` groups with chronological splits, one-session embargo, no shuffle, and no lookahead.
- Walk-forward: `4` folds and `3024` evaluation rows.
- OOS: `2988` evaluation rows and accuracy range `0.119813 to 0.480924`.
- Model comparison: `5` groups, `7` deterministic comparisons, and `3` unavailable model-family requests preserved as `NOT_EVALUATED_MODEL_FAMILY_UNAVAILABLE`.
- Leakage/data quality: `PASS` with `0` failed controls / `PASS_WITH_PRESERVED_SOURCE_LIMITATION`.

## Reassessment Classification

- Status: `COMPLETED_RESEARCH_ONLY`.
- Refined predictive-signal consistency: `WEAK_OR_MIXED`.
- Baseline-outperformance consistency: `INSUFFICIENT_OR_MIXED`.
- OOS assessment: `LOW_TO_MIXED_NOT_ACCEPTANCE_EVIDENCE`.
- Model comparison: `RESEARCH_ONLY_NOT_ACCEPTANCE_EVIDENCE`.
- Calibration/stability: `NOT_ACCEPTANCE_EVIDENCE_UNTIL_READINESS_REVIEW`.
- Leakage/data quality: `PASS` / `PASS_WITH_PRESERVED_SOURCE_LIMITATION`.
- META limitation: `PRESERVED_REQUIRES_OPERATOR_AWARENESS`.
- The reassessment supports only a future acceptance-readiness review rerun. It neither supports direct acceptance nor recommends acceptance.

## Review Domains

- Label and feature coverage: `REVIEWED_RESEARCH_ONLY`.
- Protocol: `PASS_RESEARCH_ONLY`.
- Walk-forward: `WEAK_OR_MIXED_REQUIRES_READINESS_REVIEW`.
- OOS: `LOW_TO_MIXED_REQUIRES_READINESS_REVIEW`.
- Baseline/model comparison: `INSUFFICIENT_OR_MIXED`.
- Calibration/stability: `NOT_ACCEPTANCE_EVIDENCE_UNTIL_READINESS_REVIEW`.
- Leakage/data quality: `PASS` / `PASS_WITH_PRESERVED_SOURCE_LIMITATION`.
- META record review: `PRESERVED_REQUIRES_OPERATOR_AWARENESS`.
- Operator acceptance boundary: `ACCEPTANCE_NOT_GRANTED`.
- Every domain remains `RESEARCH_ONLY_NON_ACTIONABLE` and `NOT_ACCEPTANCE`.

## Per-Ticker Reassessment Summary

- Twelve entries are present in exact universe order, each with a deterministic per-ticker digest and the source refined-results-review digest.
- MSFT, NVDA, AMZN, GOOGL, TSLA, JPM, XOM, JNJ, WMT, CAT, and LMT each preserve `1003` records.
- META preserves exactly `913` records and the note `PRESERVE_REDUCED_RECORD_COUNT_AND_INCLUDE_LIMITATION_FLAG_IN_REASSESSMENT_RERUN`.
- Every entry remains research-only with predictive usefulness and profitability `not accepted`, and runtime/strategy/paper/broker `NOT_AUTHORIZED`.

## Future Chain And Gates

1. Predictive Usefulness Acceptance Readiness Review Rerun Using Refined Evidence.
2. Predictive Usefulness Acceptance Candidate, only if readiness passes.
3. Predictive Usefulness Acceptance Ceremony, only if separately approved.
4. Profitability review chain, if separately required.
5. Runtime migration chain, if ever separately authorized.

- All five future planned outputs remain `PLANNED_NOT_GENERATED` and `RESEARCH_ONLY_NON_ACTIONABLE`.
- No later artifact or authority is created by this reassessment rerun.

## Risk Controls And Authority Boundaries

- No predictive-usefulness acceptance from reassessment; no acceptance without a separate readiness review and ceremony.
- No profitability acceptance without a separate review; no runtime source switch, automatic stitching, paper trading, broker execution, or trade recommendation.
- The frozen canonical dataset and refined evidence are not mutated or rerun; META's reduced count is preserved.
- Low-to-mixed OOS performance, model comparison, and calibration/stability are not acceptance evidence by themselves.
- Predictive usefulness and profitability remain `not accepted`; acceptance readiness/recommendation/candidate remain `False`.
- Runtime migration remains unapproved/inactive; runtime, strategy, paper, and broker remain `NOT_AUTHORIZED`.

## Offline Guardrails And Next Task

- Provider requests, live transport, market-data acquisition, dataset generation, and canonical regeneration: all `False`.
- Feature/label refinement, refined label/feature generation, walk-forward/OOS reassessment, metrics, model comparison, and refined additional-predictive-evidence execution were not rerun.
- No API key or `.env` was inspected, stored, or printed; no strategy scoring or trade recommendation occurred.
- The follow-on Predictive Usefulness Acceptance Readiness Review Rerun Using Refined Evidence v1 is implemented. This reassessment rerun remains its bound source evidence.
- The readiness rerun does not accept predictive usefulness. Its current decision is `PREDICTIVE_USEFULNESS_ACCEPTANCE_NOT_READY_USING_REFINED_EVIDENCE`.
- Profitability remains `not accepted`; runtime remains `NOT_AUTHORIZED`.
- Next task recommendation: `Refined Evidence Improvement Candidate v1`, if desired, or pause before any further improvement cycle.
